Jared Holz, Mizuho, joins ‘Fast Money’ to talk competition in the GLP-1 pill space between Novo Nordisk and Eli Lilly.
Source link
Trending
- Chart Master: Trim longs in Alibaba
- Mark Zuckerberg unveils $799 Meta Ray-Ban Display glasses
- Netskope prices IPO at $19, valuing company at $7.3 billion
- Asia-Pacific markets set to open mixed after Fed cut rates as expected
- A bullish options trade on this banking giant that’s in the midst of a turnaround
- Market delayed in reaction to Novo Nordisk and Eli Lilly' s GLP-1 pills, says Mizuho's Jared Holz
- ABC pulls Jimmy Kimmel show over Charlie Kirk comments
- Abu Dhabi’s XRG withdraws $19 billion offer for Australia’s Santos
Market delayed in reaction to Novo Nordisk and Eli Lilly' s GLP-1 pills, says Mizuho's Jared Holz
